PharmaLundensis AB
PHAL
PHAL
| Transactions d'initiés
Signaux d'activité des initiés
0 activity signals detected for PharmaLundensis AB
Les transactions d’initiés n’ont pas déclenché de signaux d’activité inhabituelle pour cette société.
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2026-07-05 | 2026-07-01 | V Vente |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
53 493
29,53
3 104 147 SEK |
53 493 | 29,53 | 3 104 147 SEK | |
| 2026-06-08 | 2026-06-04 | V Vente |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
20 907
344,78
296 516 SEK |
20 907 | 344,78 | 296 516 SEK | |
| 2026-02-24 | 2026-02-20 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
97 761
272,28
2 318 244 SEK |
97 761 | 272,28 | 2 318 244 SEK | |
| 2025-10-04 | 2025-10-01 | V Vente |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
223 693
0,64
143 164 SEK |
223 693 | 0,64 | 143 164 SEK | |
| 2025-09-25 | 2025-09-24 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
92 333
0,19
17 543 SEK |
92 333 | 0,19 | 17 543 SEK | |
| 2025-09-25 | 2025-09-24 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
63 017
0,22
13 864 SEK |
63 017 | 0,22 | 13 864 SEK | |
| 2025-09-25 | 2025-09-23 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
65 656
0,20
13 131 SEK |
65 656 | 0,20 | 13 131 SEK | |
| 2025-03-12 | 2025-03-11 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
2 337
0,85
1 986 SEK |
2 337 | 0,85 | 1 986 SEK | |
| 2025-03-10 | 2025-03-06 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
3 713
0,85
3 156 SEK |
3 713 | 0,85 | 3 156 SEK | |
| 2025-03-10 | 2025-02-27 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
200 000
1,00
200 000 SEK |
200 000 | 1,00 | 200 000 SEK | |
| 2025-01-21 | 2025-01-17 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
121 700
0,79
96 143 SEK |
121 700 | 0,79 | 96 143 SEK | |
| 2025-01-21 | 2025-01-17 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
10 958
0,73
7 999 SEK |
10 958 | 0,73 | 7 999 SEK | |
| 2024-10-16 | 2024-10-14 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
49 370
0,40
19 748 SEK |
49 370 | 0,40 | 19 748 SEK | |
| 2024-10-13 | 2024-10-09 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
27 936
0,37
10 336 SEK |
27 936 | 0,37 | 10 336 SEK | |
| 2024-09-30 | 2024-09-26 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
63 000
0,47
29 610 SEK |
63 000 | 0,47 | 29 610 SEK | |
| 2024-09-25 | 2024-09-25 | A Achat |
Chairman of the Board of Directors Administrateur |
800 000
0,50
400 000 SEK |
800 000 | 0,50 | 400 000 SEK | |
| 2024-09-24 | 2024-09-23 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
200 000
0,50
100 000 SEK |
200 000 | 0,50 | 100 000 SEK | |
| 2024-09-27 | 2024-09-20 | A Achat |
Member of the Board of Directors Administrateur |
60 000
0,46
27 600 SEK |
60 000 | 0,46 | 27 600 SEK | |
| 2024-09-21 | 2024-09-20 | A Achat |
Member of the Board of Directors Administrateur |
60 000
0,46
27 600 SEK |
60 000 | 0,46 | 27 600 SEK | |
| 2024-09-19 | 2024-09-17 | A Achat |
Chief Executive Officer (CEO)/Managing Directory Dirigeant |
3 999 999
0,50
2 000 000 SEK |
3 999 999 | 0,50 | 2 000 000 SEK |
Plus de recherches sur les transactions d'initiés autour de PharmaLundensis AB
